Ecto-Nucleoside Triphosphate Diphosphohydrolase 2 Modulates Local ATP-Induced Calcium Signaling in Human HaCaT Keratinocytes

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Ho, Chia Lin ^a   Yang, Chih Yung ^a,b   Lin, Wen Jie ^a   Lin, Chi Hung ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI CITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CALCIUM; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; PHOSPHATASE; PURINERGIC P2Y2 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HYDROLYSIS; KERATINOCYTE; PROTEIN EXPRESSION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; CALCIUM; CALCIUM SIGNALING; CELL LINE; CELL MEMBRANE; EXTRACELLULAR SPACE; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYDROLYSIS; INTRACELLULAR SPACE; KERATINOCYTES; RECEPTORS, PURINERGIC P2Y; RECEPTORS, PURINERGIC P2Y2;

EID: 84874860497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057666     Document Type: Article

References (58)

1. Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, et al. (2012) Structure and function of the epidermis related to barrier properties. Clinics in Dermatology 30: 257-262.
2. Proksch E, Brandner JM, Jensen JM, (2008) The skin: an indispensable barrier. Experimental Dermatology 17: 1063-1072.
3. Wickett RR, Visscher MO, (2006) Structure and function of the epidermal barrier. American Journal of Infection Control 34: S98-S110.
4. Boulais N, Misery L, (2008) The epidermis: a sensory tissue. European Journal of Dermatology 18: 119-127.
5. Roosterman D, Goerge T, Schneider SW, Bunnett NW, Steinhoff M, (2006) Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 86: 1309-1379.
6. Lumpkin EA, Caterina MJ, (2007) Mechanisms of sensory transduction in the skin. Nature 445: 858-865.
7. Reichelt J, (2007) Mechanotransduction of keratinocytes in culture and in the epidermis. European Journal of Cell Biology 86: 807-816.
8. Celleno L, Tamburi F (2009) Chapter 1- Structure and Function of the Skin. In: Aaron T, Md, Ceo, Robert MB, editors. Nutritional Cosmetics. Boston: William Andrew Publishing. pp. 3-45.
9. Powell J, (2006) Skin physiology. Women's Health Medicine 3: 130-133.
10. Holzer AM, Granstein RD, (2004) Role of extracellular adenosine triphosphate in human skin. Journal of Cutaneous Medicine and Surgery 8: 90-96.
11. Mandadi S, Sokabe T, Shibasaki K, Katanosaka K, Mizuno A, et al. (2009) TRPV3 in keratinocytes transmits temperature information to sensory neurons via ATP. Pflugers Archiv European Journal of Physiology 458: 1093-1102.
12. Azorin N, Raoux M, Rodat-Despoix L, Merrot T, Delmas P, et al. (2011) ATP signalling is crucial for the response of human keratinocytes to mechanical stimulation by hypo-osmotic shock. Experimental Dermatology 20: 401-407.
13. Tsutsumi M, Inoue K, Denda S, Ikeyama K, Goto M, et al. (2009) Mechanical-stimulation-evoked calcium waves in proliferating and differentiated human keratinocytes. Cell and Tissue Research 338: 99-106.
14. Tsutsumi M, Goto M, Denda S, Denda M, (2011) Morphological and functional differences in coculture system of keratinocytes and dorsal-root-ganglion-derived cells depending on time of seeding. Experimental Dermatology 20: 464-467.
15. Yoshida H, Kobayashi D, Ohkubo S, Nakahata N, (2006) ATP stimulates interleukin-6 production via P2Y receptors in human HaCaT keratinocytes. Eur J Pharmacol 540: 1-9.
16. Burnstock G, (2007) Purine and pyrimidine receptors. Cell Mol Life Sci 64: 1471-1483.
17. Ralevic V, Burnstock G, (1998) Receptors for Purines and Pyrimidines. Pharmacological Reviews 50: 413-492.
18. Volonte C, Amadio S, D'Ambrosi N, Colpi M, Burnstock G, (2006) P2 receptor web: complexity and fine-tuning. Pharmacology and Therapeutics 112: 264-280.
19. Burrell HE, Bowler WB, Gallagher JA, Sharpe GR, (2003) Human keratinocytes express multiple P2Y-receptors: evidence for functional P2Y1, P2Y2, and P2Y4 receptors. J Invest Dermatol 120: 440-447.
20. Greig AV, Linge C, Cambrey A, Burnstock G, (2003) Purinergic receptors are part of a signaling system for keratinocyte proliferation, differentiation, and apoptosis in human fetal epidermis. J Invest Dermatol 121: 1145-1149.
21. Burnstock G, Verkhratsky A, (2010) Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis 1: e9.
22. Satoh E, Tsukimoto M, Kojima S, (2011) Involvement of P2Y receptors in the protective effect of ATP towards the cell damage in HaCaT cells exposed to H(2)O(2). Journal of Toxicological Sciences 36: 741-750.
23. Taboubi S, Garrouste F, Parat F, Pommier G, Faure E, et al. (2010) Gq-coupled purinergic receptors inhibit insulin-like growth factor-I/phosphoinositide 3-kinase pathway-dependent keratinocyte migration. Mol Biol Cell 21: 946-955.
24. Pastore S, Mascia F, Gulinelli S, Forchap S, Dattilo C, et al. (2007) Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. J Invest Dermatol 127: 660-667.
25. Inoue K, Hosoi J, Denda M, (2007) Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes. J Invest Dermatol 127: 362-371.
26. Kobayashi D, Ohkubo S, Nakahata N, (2006) Contribution of extracellular signal-regulated kinase to UTP-induced interleukin-6 biosynthesis in HaCaT keratinocytes. J Pharmacol Sci 102: 368-376.
27. Burnstock G, Knight GE, Greig AV, (2011) Purinergic Signaling in Healthy and Diseased Skin. J Invest Dermatol.
28. Knight GE (2009) Purinergic Receptors. In: Editor-in-Chief: Larry RS, editor. Encyclopedia of Neuroscience. Oxford: Academic Press.pp. 1245-1252.
29. Robson S, Sévigny J, Zimmermann H, (2006) The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance. Purinergic Signalling 2: 409-430.
30. Stefan C, Jansen S, Bollen M, (2006) Modulation of purinergic signaling by NPP-type ectophosphodiesterases. Purinergic Signal 2: 361-370.
31. Yegutkin GG, (2008) Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. Biochimica et Biophysica Acta 1783: 673-694.
32. Zimmermann H, (2000) Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 362: 299-309.
33. Zimmermann H, Zebisch M, Strater N, (2012) Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal 8: 437-502.
34. Kukulski F, Levesque SA, Sevigny J, (2011) Impact of ectoenzymes on p2 and p1 receptor signaling. Advances in Pharmacology 61: 263-299.
35. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, et al. (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. Journal of Cell Biology 106: 761-771.
36. Levesque SA, Lavoie EG, Lecka J, Bigonnesse F, Sevigny J, (2007) Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases. Br J Pharmacol 152: 141-150.
37. Kukulski F, Levesque SA, Lavoie EG, Lecka J, Bigonnesse F, et al. (2005) Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic Signal 1: 193-204.
38. Koizumi S, Fujishita K, Inoue K, Shigemoto-Mogami Y, Tsuda M, (2004) Ca2+ waves in keratinocytes are transmitted to sensory neurons: the involvement of extracellular ATP and P2Y2 receptor activation. Biochem J 380: 329-338.
39. Dixon CJ, Bowler WB, Littlewood-Evans A, Dillon JP, Bilbe G, et al. (1999) Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 127: 1680-1686.
40. Burrell HE, Wlodarski B, Foster BJ, Buckley KA, Sharpe GR, et al. (2005) Human Keratinocytes Release ATP and Utilize Three Mechanisms for Nucleotide Interconversion at the Cell Surface. Journal of Biological Chemistry 280: 29667-29676.
41. Lazarowski ER, (2012) Vesicular and conductive mechanisms of nucleotide release. Purinergic Signal 8: 359-373.
42. Praetorius HA, Leipziger J, (2009) ATP release from non-excitable cells. Purinergic Signal 5: 433-446.
43. Fitz JG, (2007) Regulation of cellular ATP release. Transactions of the American Clinical and Climatological Association 118: 199-208.
44. Corriden R, Insel PA, (2010) Basal Release of ATP: An Autocrine-Paracrine Mechanism for Cell Regulation. Sci Signal 3re1.
45. Beigi R, Kobatake E, Aizawa M, Dubyak GR, (1999) Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. American Journal of Physiology 276: C267-278.
46. Beis I, Newsholme EA, (1975) The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates. Biochem J 152: 23-32.
47. Jhandier MN, Kruglov EA, Lavoie EG, Sevigny J, Dranoff JA, (2005) Portal fibroblasts regulate the proliferation of bile duct epithelia via expression of NTPDase2. J Biol Chem 280: 22986-22992.
48. Alvarado-Castillo C, Lozano-Zarain P, Mateo J, Harden TK, Boyer JL, (2002) A fusion protein of the human P2Y(1) receptor and NTPDase1 exhibits functional activities of the native receptor and ectoenzyme and reduced signaling responses to endogenously released nucleotides. Molecular Pharmacology 62: 521-528.
49. Kauffenstein G, Furstenau CR, D'Orleans-Juste P, Sevigny J, (2010) The ecto-nucleotidase NTPDase1 differentilly regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation. Br J Pharmacol 159: 576-585.
50. Schicker K, Hussl S, Chandaka GK, Kosenburger K, Yang JW, et al. (2009) A membrane network of receptors and enzymes for adenine nucleotides and nucleosides. Biochimica et Biophysica Acta 1793: 325-334.
51. Alvarado-Castillo C, Harden TK, Boyer JL, (2005) Regulation of P2Y1 Receptor-Mediated Signaling by the Ectonucleoside Triphosphate Diphosphohydrolase Isozymes NTPDase1 and NTPDase2. Molecular Pharmacology 67: 114-122.
52. Kauffenstein G, Drouin A, Thorin-Trescases N, Bachelard H, Robaye B, et al. (2010) NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse. Cardiovascular Research 85: 204-213.
53. Munkonda MN, Kauffenstein G, Kukulski F, Levesque SA, Legendre C, et al. (2007) Inhibition of human and mouse plasma membrane bound NTPDases by P2 receptor antagonists. Biochemical Pharmacology 74: 1524-1534.
54. Chen BC, Lee CM, Lin WW, (1996) Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br J Pharmacol 119: 1628-1634.
55. von Kugelgen I, (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacology & Therapeutics 110: 415-432.
56. Marteau F, Le Poul E, Communi D, Communi D, Labouret C, et al. (2003) Pharmacological characterization of the human P2Y13 receptor. Molecular Pharmacology 64: 104-112.
57. Taboubi S, Milanini J, Delamarre E, Parat F, Garrouste F, et al. (2007) G alpha(q/11)-coupled P2Y2 nucleotide receptor inhibits human keratinocyte spreading and migration. FASEB J 21: 4047-4058.
58. Kobayashi D, Ohkubo S, Nakahata N, (2007) Cooperation of calcineurin and ERK for UTP-induced IL-6 production in HaCaT keratinocytes. Eur J Pharmacol 573: 249-252.